In Canada, Improving Cancer-Related Outcomes in Shift Workers (NCT02609373) evaluated sleep-behavior interventions to reduce circadian disruption
Pasquel, MD, MPH, an associate professor of medicine and global health at Emory School of Medicine, said that patients initiating GLP-1s should be counseled about the rare but serious risk for NAION, especially if they have preexisting optic-disc crowding. Meanwhile, patients with DR require close ophthalmic monitoring when [incretin receptor agonists (IRAs)] are initiated or intensified, they wrote
144 GLP-1RAs and gastrointestinal cancers GLP-1 and its receptor agonists show some potential in the treatment of gastrointestinal cancers, although this remains an emerging area of research
International Orders: Returns are accepted only for damaged/defective/wrong products and are valid 15 days after your order is received
Understanding Growth Hormone Testing: What You Need to Know Before beginning any growth hormone therapy, comprehensive testing is essential to establish baseline levels, confirm deficiency, and monitor your response to treatment